(Q27011650)

language of work or name

1 reference

May 2013

1 reference

published in

Arthritis & Rheumatology

1 reference

volume

65

1 reference

issue

5

1 reference

page(s)

1137-47

1 reference

A candidate gene for familial Mediterranean fever

cites work

1 reference

Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever

21 January 2018

1 reference

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

21 January 2018

1 reference

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

21 January 2018

1 reference

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

21 January 2018

1 reference

The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles

21 January 2018

1 reference

NOD-like receptor (NLR) signaling beyond the inflammasome

21 January 2018

1 reference

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

21 January 2018

1 reference

Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations

21 January 2018

1 reference

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

21 January 2018

1 reference

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

21 January 2018

1 reference

Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease

21 January 2018

1 reference

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

21 January 2018

1 reference

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome

21 January 2018

1 reference

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

21 January 2018

1 reference

The Nalp3 inflammasome is essential for the development of silicosis

21 January 2018

1 reference

Disease-associated amyloid and misfolded protein aggregates activate the inflammasome

21 January 2018

1 reference

A pilot study of IL-1 inhibition by anakinra in acute gout

21 January 2018

1 reference

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

21 January 2018

1 reference

Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse

21 January 2018

1 reference

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

21 January 2018

1 reference

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

21 January 2018

1 reference

A proposed classification of the immunological diseases

21 January 2018

1 reference

Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature

21 January 2018

1 reference

The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production

21 January 2018

1 reference

The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment

21 January 2018

1 reference

The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing

21 January 2018

1 reference

Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants

21 January 2018

1 reference

Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia

21 January 2018

1 reference

Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice

21 January 2018

1 reference

Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway

21 January 2018

1 reference

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

21 January 2018

1 reference

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

21 January 2018

1 reference

CARD15 mutations in Blau syndrome

21 January 2018

1 reference

NOD2-associated diseases: Bridging innate immunity and autoinflammation

21 January 2018

1 reference

The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity

21 January 2018

1 reference

PSORS2 is due to mutations in CARD14.

21 January 2018

1 reference

Mutations in NALP12 cause hereditary periodic fever syndromes

21 January 2018

1 reference

The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals

21 January 2018

1 reference

Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation

21 January 2018

1 reference

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

21 January 2018

1 reference

DAMPs and inflammatory processes: the role of redox in the different outcomes

21 January 2018

1 reference

Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response.

21 January 2018

1 reference

Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome

21 January 2018

1 reference

Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion

21 January 2018

1 reference

Interplay between redox status and inflammasome activation.

21 January 2018

1 reference

Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications

21 January 2018

1 reference

Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)

21 January 2018

1 reference

Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes

21 January 2018

1 reference

Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome

21 January 2018

1 reference

Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)

21 January 2018

1 reference

The interplay between endoplasmic reticulum stress and inflammation.

21 January 2018

1 reference

Autophagy in immunity and inflammation

21 January 2018

1 reference

Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome

21 January 2018

1 reference

Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome

21 January 2018

1 reference

Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study

21 January 2018

1 reference

Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome.

21 January 2018

1 reference

Hyperimmunoglobulinaemia D and periodic fever: a new syndrome

21 January 2018

1 reference

Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome

21 January 2018

1 reference

The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.

21 January 2018

1 reference

Membrane targeting mechanism of Rab GTPases elucidated by semisynthetic protein probes

21 January 2018

1 reference

Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities

21 January 2018

1 reference

PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome

21 January 2018

1 reference

Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.

21 January 2018

1 reference

Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.

21 January 2018

1 reference

A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans

21 January 2018

1 reference

Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions

21 January 2018

1 reference

Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.

21 January 2018

1 reference

Inflammasomes in health and disease

21 January 2018

1 reference

Novel aspects of mevalonate pathway inhibitors as antitumor agents

21 January 2018

1 reference

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.37882

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23400910

1 reference

Consolidated OpenCitations Corpus – April 2017